Suchergebnisse - "López, Pío"

PubPharm (5)

1

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003) : 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Global health | 2024

von Tricou, V. | Yu, D. | Reynales, H. | +29

2

Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years : a randomised, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2020

von Biswal, S. | Borja-Tabora, C. | Martinez Vargas, L. | +67

CommentIn: Lancet. 2020 May 2;395(10234):1402-1404. - PMID 32197106

3

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

enthalten in: The New England journal of medicine | 2019

von Biswal, S. | Reynales, H. | Saez-Llorens, X. | +39

CommentIn: N Engl J Med. 2020 Apr 30;382(18):1769. - PMID 32348658

4

Safety Follow-up of a Dengue Vaccine When Administered Concomitantly with a Yellow Fever Vaccine in Healthy Toddlers in Colombia

enthalten in: The Pediatric infectious disease journal | 2018

von Cortés, M. | López, P. | Márquez, V. | +4

5

Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru : A Randomized Trial

enthalten in: The Pediatric infectious disease journal | 2016

von López, P. | Lanata, C. | Zambrano, B. | +10

1
[1]